Dosage

Mounjaro Dosage Guide: Titration Schedule from 2.5mg to 15mg

GLP-1 Companion · 6 min read

Mounjaro (tirzepatide) is a dual GIP/GLP-1 receptor agonist approved for type 2 diabetes and chronic weight management. Unlike medications that target only one hormone pathway, Mounjaro works on two incretin receptors simultaneously, which contributes to its strong clinical results. However, reaching the full therapeutic dose requires a careful, step-by-step titration process.

Why Titration Matters

Titration means gradually increasing your dose over time rather than starting at the highest level. This approach lets your body adapt to the medication, significantly reducing gastrointestinal side effects like nausea, vomiting, and diarrhea. Skipping steps or increasing too quickly is one of the most common reasons patients discontinue treatment prematurely.

The Standard Mounjaro Titration Schedule

Mounjaro is administered as a once-weekly subcutaneous injection. The FDA-approved titration schedule follows a structured progression through six available dose levels.

1. 2.5mg weekly for 4 weeks — This is the starting dose for all patients. It is primarily an initiation dose to acclimate your body to the medication, not a therapeutic dose for weight loss.
2. 5mg weekly for at least 4 weeks — The first dose where meaningful appetite suppression and metabolic effects begin. Many patients start to notice reduced hunger at this level.
3. 7.5mg weekly for at least 4 weeks — An intermediate step that continues to build tolerance. Weight loss typically accelerates during this phase.
4. 10mg weekly for at least 4 weeks — A commonly used maintenance dose. Many patients achieve significant results at this level and may not need to increase further.
5. 12.5mg weekly for at least 4 weeks — A higher dose for patients who need additional effect beyond 10mg.
6. 15mg weekly — The maximum approved dose. Reserved for patients who have not reached adequate response at lower doses.

What Happens at Each Dose Level

2.5mg: The Starting Phase

During the first four weeks at 2.5mg, most patients experience mild side effects as their body adjusts. Common symptoms include mild nausea (especially in the first 48 hours after injection), decreased appetite, and occasional stomach discomfort. Some patients report little to no weight change at this dose, which is completely normal — this phase is about building tolerance.

5mg–7.5mg: Early Therapeutic Range

At 5mg, most patients begin experiencing noticeable appetite reduction and early weight loss. The transition from 5mg to 7.5mg is where many patients see their first significant drop in body weight. Gastrointestinal side effects may briefly intensify with each increase but typically subside within one to two weeks.

10mg–15mg: Full Therapeutic Range

The higher doses (10mg, 12.5mg, and 15mg) deliver the strongest metabolic effects. Clinical trials showed that patients on 15mg lost an average of 22.5% of their body weight over 72 weeks. Not every patient needs to reach 15mg — your healthcare provider will determine the right maintenance dose based on your response and tolerance.

Managing Side Effects During Titration

Side effects are most common in the first few weeks at each new dose level. Knowing what to expect and how to manage symptoms can make the process much smoother.

• Nausea — Eat smaller, more frequent meals. Avoid greasy, fried, or very rich foods. Bland foods like crackers, toast, and rice can help.
• Constipation — Increase water intake to at least 64 ounces per day. Add fiber-rich foods gradually and consider a stool softener if needed.
• Diarrhea — Stay hydrated with water and electrolyte drinks. Avoid high-fat and high-sugar foods.
• Reduced appetite — Even if you do not feel hungry, aim for at least 1,000-1,200 calories per day to prevent muscle loss and nutrient deficiencies.
• Injection site reactions — Rotate injection sites between the abdomen, thigh, and upper arm. Allow the pen to reach room temperature before injecting.

When to Stay at a Dose vs. Move Up

There is no requirement to reach the maximum dose. If you are losing weight steadily, feeling well, and meeting your health goals at a lower dose, your provider may recommend staying there. Conversely, if side effects are severe at a new dose, your provider might keep you at the previous level for an additional four weeks before trying again.

The best dose is the lowest dose that achieves your treatment goals with tolerable side effects. More medication does not always mean better results.

Timing and Injection Tips

• Inject on the same day each week. If you need to change your injection day, ensure at least 72 hours have passed since your last dose.
• Mounjaro can be injected at any time of day, with or without food.
• Store unused pens in the refrigerator (36°F to 46°F). A pen can be kept at room temperature (up to 86°F) for up to 21 days.
• Each pen is single-use. Do not reuse pens even if medication appears to remain.

Tracking Your Progress

Keeping a record of your dose, injection dates, side effects, and weight changes can be extremely valuable during titration. This data helps your healthcare provider make informed decisions about dose adjustments and gives you a clear picture of how your body is responding over time.

Key Takeaways

• Mounjaro titration follows a structured schedule from 2.5mg to a maximum of 15mg.
• Each dose level should be maintained for at least four weeks before increasing.
• Side effects are most common during the first one to two weeks at each new dose.
• Not all patients need to reach the maximum dose — the right dose is the one that works for you.
• Always follow your healthcare provider's guidance on dose adjustments.

Sources

• Mounjaro (tirzepatide) Prescribing Information. Eli Lilly.
• Jastreboff et al. (2022). Tirzepatide Once Weekly for the Treatment of Obesity. NEJM.